molybdenum disulfide has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, J; Guo, F; Li, G; Liang, J; Wu, R; Yan, R; Yao, X; Zhou, Z | 1 |
| Celichowski, G; Domeradzka-Gajda, K; Grobelny, J; Kowalczyk, K; Ranoszek-Soliwoda, K; Sobańska, Z; Stępnik, M; Szparaga, M; Tomaszewska, E; Zapór, L | 1 |
| Chen, S; Liu, H; Nie, Z; Sun, J; Xiong, C; Xue, J; Zhan, L | 1 |
3 other study(ies) available for molybdenum disulfide and Liver Neoplasms
| Article | Year |
|---|---|
A novel fluorescent strategy for Golgi protein 73 determination based on aptamer/nitrogen-doped graphene quantum dots/molybdenum disulfide @ reduced graphene oxide nanosheets.
Topics: Aptamers, Nucleotide; Biosensing Techniques; Carcinoma, Hepatocellular; Graphite; Humans; Liver Neoplasms; Molybdenum; Nitric Oxide; Nitrogen; Nitrogen Oxides; Quantum Dots | 2023 |
Comparative analysis of biological effects of molybdenum(IV) sulfide in the form of nano- and microparticles on human hepatoma HepG2 cells grown in 2D and 3D models.
Topics: Carcinoma, Hepatocellular; Cell Survival; Disulfides; Drug Carriers; Hep G2 Cells; Humans; Liver Neoplasms; Models, Biological; Molybdenum; Nanoparticles; Particle Size | 2020 |
Mass spectrometry imaging of the in situ drug release from nanocarriers.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Disulfides; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Liver Neoplasms; Mice; Mice, Inbred BALB C; Molybdenum; Nanotubes, Carbon; Polyethylene Glycols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |